NEW YORK, June 13, 2017 /PRNewswire/ --
On Monday, the NASDAQ Composite ended the day at 6,175.47, down 0.52%; theDow Jones Industrial Average edged 0.17% lower, to finish at 21,235.67; and the S&P 500 closed at 2,429.39, slightly slipping 0.10%. Five out of nine sectors finished the trading session in red. DailyStockTracker.com has initiated research reports
Ewing, New Jersey headquartered Antares Pharma Inc.'s stock finished Monday's session 1.77% lower at $2.78. A total volume of 1.81 million shares was traded, which was above their three months average volume of 1.36 million shares. The Company's shares have advanced 3.73% in the past month, 11.65% in the previous three months, and 19.31% since the start of this year. The stock is trading 0.27% above its 50-day moving average and 25.98% above its 200-day moving average. Additionally, shares of Antares Pharma, which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide, have a Relative Strength Index (RSI) of 56.94. ATRS complete research report is just a click away and free at:
On Monday, shares in Franklin Lakes, New Jersey headquartered Becton, Dickinson and Co. recorded a trading volume of 1.74 million shares. The stock ended the session 0.52% lower at $191.00. The Company's shares have advanced 3.32% in the last one month, 3.30% in the previous three months, and 15.37% on an YTD basis. The stock is trading 3.16% above its 50-day moving average and 7.76% above its 200-day moving average. Moreover, shares of Becton, Dickinson and Co., which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide, have an RSI of 59.51. The complimentary report on BDX can be downloaded at:
Plainsboro, New Jersey headquartered Integra LifeSciences Holdings Corp.'s shares closed the day 0.08% lower at $51.78. The stock recorded a trading volume of 547,689 shares. The Company's shares have gained 10.76% in the last month, 18.54% over the previous three months, and 20.71% on an YTD basis. The stock is trading 13.05% and 20.78% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Integra LifeSciences, which develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery, have an RSI of 76.64. Sign up for your complimentary research report on IART at:
Shares in Milford, Massachusetts-based Waters Corp. finished 0.89% lower at $183.35. The stock recorded a trading volume of 536,473 shares, which was higher than its three months average volume of 477,100 shares. The Company's shares have advanced 6.46% in the last one month, 16.66% in the previous three months, and 36.43% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 7.95% and 19.61%, respectively. Furthermore, shares of Waters, which operates as an analytical instrument manufacturer in the US and internationally, have an RSI of 70.19. Get free access to your research report on WAT at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All